This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the following U.S. Patents and Patent Applications to Bavarian Nordic Immunotherapeutics (``BNIT'') located in Mountain View, CA, USA.
This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive license in the United States to practice the invention described and claimed in U.S. Patent Application Serial No. US 13/ 534,804, Alpha-Stream Convertor, LEW 18802-1; and U.S. Provisional Patent Application Serial No. US 61/677,116, Magnetostrictive Alternator--Low Cost, No Moving Part, High Efficiency, Oscillating Acoustic Pressure Wave to Electric Power Transducer, LEW 18939-1, to Nirvana Energy Systems, having its principal place of business in Portolo Valley, California. The fields of use may be limited to power systems for residential, commercial and transportation industries. The patent rights in these inventions as applicable have been...
This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a co-exclusive license in the United States to practice the invention described and claimed in MFS-31303-1 Generalized Fluid Systems Simulation Program (GFSSP) Version 2.01, U.S. Patent No. 6,748,349 and MFS-32125-1 Method and Apparatus For Predicting Unsteady Pressure And Flow Rate Distribution In A Fluid Network Version 4, U.S. Patent No. 7,542,885, to MODE Technology Group, having its principal place of business in Denver, CO. The fields of use shall mean commercial off- the-shelf software products targeted to end users. The patent rights in these inventions as applicable have been assigned to the United States of America as represented by the Administr...
This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive license to practice the inventions described and claimed in NASA Case Number(s) LAR-16079-1 entitled ``Liquid Crystalline Thermosets From Oligo-Esters, Ester-Imides And Ester-Amides,'' U.S. Patent Number 6,939,940; LAR-17157-1 entitled ``Liquid Crystalline Thermosets From Ester, Ester-Imide, And Ester-Amide Oligomers'' U.S. Patent Number 7,507,784; and LAR-17402-1 entitled ``Wholly Aromatic Liquid Crystalline Polyetherimide (LC-PEI) Resins,'' U.S. Patent Number 7,964,698, to Allotropica Technologies, Incorporated having its principal place of business in Chapel Hill, North Carolina. The patent rights have been assigned to the United States of ...
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a start-up exclusive commercial license agreement to practice the inventions embodied in International PCT Application S/N PCT/US03/23317 (HHS Ref. No. E-113-2003/0-PCT-02) filed July 23, 2003, which published as WO 2004/068104 on August 12, 2004, now expired; U.S. Patent No. 7,709,047 (HHS Ref. No. E-113-2003/0-US-03) issued May 4, 2010; U.S. Patent Application S/N 12/753,566 (HHS Ref. No. E-113-2003/0-US-07) filed April 2, 2010; U.S. Patent No. 7,695,752 (HHS Ref. No. E-113- 2003/1-US-01) issued April 13, 2010; U.S. Patent Application S/N 12/ 713,105 (HHS Ref. No. E-113-2003/1-US-02) filed ...
This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive license in the United States to practice the invention described and claimed in U.S. Patent Nos. 7,113,820 entitled, ``Real- Time, High Frequency QRS Electrocardiograph,'' 7,539,535 entitled, ``Real-Time, High Frequency QRS Electrocardiograph with Reduced Amplitude Zone Detection,'' and 7,386,340 entitled, ``System for Diagnosis and Monitoring of Coronary Artery Disease, Acute Coronary Artery Syndromes, Cardiomyopathy and Other Cardiac Conditions,'' to Medcare Holdings, LTD, having its principal place of business at P.O. Box 3483, Road Town, Tortola, British Virgin Islands. The patent rights in these inventions have been assigned to the United...
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of a worldwide exclusive patent license to practice the inventions embodied in: HHS Ref. No. E-093-1997/0 ``Food Quality Indicator;''
The National Security Agency hereby gives notice of its intent to grant Voltage Networking, LLC a revocable, non-assignable, exclusive, license to practice the following Government-Owned inventions as described in the following: Patent No. 6,835,581 entitled ``Method of coating optical device facets with dielectric layer and device made therefrom''; Patent No. 6,541,288 entitled ``Method of determining semiconductor laser facet reflectivity after facet reflectance modification''; Patent No. 6,760,350 entitled ``Method for measuring gain of photonic inverters''; Patent No. 7,010,187 entitled ``Mode transition-discrimination photonic logic device''; Patent No. 7,599,594 entitled ``Method of fabricating waveguide using sacrificial spacer layer''; Patent No. 7,442,577 entitled ``Method of f...
This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive license in the United States to practice the invention described and claimed in U.S. Patent Nos. 7,113,820 entitled, ``Real- Time, High Frequency QRS Electrocardiograph,'' 7,539,535 entitled, ``Real-Time, High Frequency QRS Electrocardiograph with Reduced Amplitude Zone Detection,'' and 7,386,340 entitled, ``System for Diagnosis and Monitoring of Coronary Artery Disease, Acute Coronary Artery Syndromes, Cardiomyopathy and Other Cardiac Conditions,'' to Medcare Holdings, LTD, having its principal place of business at P.O. Box 3483, Road Town, Tortola, British Virgin Islands. The patent rights in these inventions have been assigned to the United...
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2013, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other interesting searches:
metallica lyrics | Michael Mansfield | Viktor Gerashchenko | frolick definition | Defensa de la Competencia | economía popular | ley transito guatemala | Registros Contables | Premier ministre
